2-(2,4-Dichlorophenyl)-2-oxoethyl 8-methyl-2-phenylquinoline-4-carboxylate

Catalog No. :
ACRAXL128
CAS No. :
355433-09-9
Molecular Formula :
C25H17Cl2NO3
Molecular Weight :
450.32

IUPAC Name:2-(2,4-dichlorophenyl)-2-oxoethyl 8-methyl-2-phenylquinoline-4-carboxylate

2-(2,4-Dichlorophenyl)-2-oxoethyl 8-methyl-2-phenylquinoline-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,4-Dichlorophenyl)-2-oxoethyl 8-methyl-2-phenylquinoline-4-carboxylate
IUPAC Name2-(2,4-dichlorophenyl)-2-oxoethyl 8-methyl-2-phenylquinoline-4-carboxylate
MDL No.MFCD02188678
Molecular FormulaC25H17Cl2NO3
Molecular Weight450.32
SMILESO=C(C1=CC(C2=CC=CC=C2)=NC3=C(C)C=CC=C13)OCC(C4=CC=C(Cl)C=C4Cl)=O
InChI KeyGLZDFKWDYSSUNP-UHFFFAOYSA-N
Synonym2-(2,4-dichlorophenyl)-2-oxoethyl 8-methyl-2-phenyl-4-quinolinecarboxylate;4-Quinolinecarboxylic acid, 8-methyl-2-phenyl-, 2-(2,4-dichlorophenyl)-2-oxoethyl ester
CAS No.355433-09-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRAXL128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPYCD326 route compound structure diagram
    ACPYCD3262631-72-3 In Stock
  4. Then
  5. ACRAXL128 route product structure diagram
    ACRAXL128355433-09-9
Inquiry

2. ACRAXL128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRAXL128 route product structure diagram
    ACRAXL128355433-09-9
Inquiry

Comments (0)